Oncolytics Biotech (ONCY) Restructuring Costs (2020 - 2025)

Oncolytics Biotech (ONCY) has 4 years of Restructuring Costs data on file, last reported at $88.65 in Q3 2025.

• On a quarterly basis, Restructuring Costs rose 4.25% year-over-year to $88.65 in Q3 2025; TTM through Sep 2025 was $2.1 million, a N/A change from a year earlier, with the FY2020 full-year figure at $434709.5, changed N/A from the prior year.
• Restructuring Costs for Q3 2025 stood at $88.65, up from $85.03 in the prior quarter.
• Over the last five years, Restructuring Costs for ONCY reached as high as $473243.1 in Q3 2021 and fell as low as $85.03 in Q3 2024.
• Historically, Restructuring Costs has averaged $157805.6 across 3 years, with a median of $88.65 in 2025.
• On a YoY basis, Restructuring Costs climbed as much as 4.25% in 2025 and fell as far as 4.25% in 2025.
• Year by year, Restructuring Costs stood at $473243.1 in 2021, then tumbled by 99.98% to $85.03 in 2024, then advanced by 4.25% to $88.65 in 2025.
• Per Business Quant data, the three most recent Restructuring Costs figures were $88.65 in Q3 2025, $85.03 in Q3 2024, and $473243.1 in Q3 2021.